Key Takeaways
- Ask how the program diagnoses and treats co-occurring conditions—integrated psychiatric care by one team beats sequencing addiction first and mental health later 4.
- Press for what trauma-informed means in daily practice, including staff training, group protocols, and how overwhelmed patients are handled without punishment 8.
- Request PTSD-specific therapy by name, such as concurrent prolonged exposure, since trauma-informed environments alone leave the underlying memories untreated 6.
- Ask what advanced tools address craving beyond group and medication, including TMS as a modest adjunct alongside FDA-approved AUD medications 19.
- Find out how wearables and remote monitoring are actually used, who reviews the data, and whether clinicians—not algorithms—act on alerts 10.
- Demand a step-down plan with booked appointments across partial hospitalization, IOP, and outpatient, since follow-up mental health care drives long-term outcomes 17.
- Ask how the program measures success, including abstinence, psychiatric symptoms, and functioning at 3, 6, and 12 months—not undefined success rates 1.
Why the Second (or Third) Call to Admissions Is Different
You already know what a rehab intake call sounds like. You’ve made this call before. Maybe more than once. And here you are, phone in hand, dialing again after a relapse that you didn’t see coming or saw coming for weeks and couldn’t stop.
That takes something. Calling admissions after prior treatment didn’t hold is not weakness. It’s a recovery skill most people never have to build. Give yourself that much before we go further.
The reason this call has to sound different from the last one is simple: length alone did not fix what happened last time, and length alone will not fix it this time. A 90-day program is only worth the extra weeks if it uses them to do things a 30-day stay cannot physically fit in. Layered trauma work. Integrated psychiatric care for depression, anxiety, PTSD, or bipolar disorder that has been quietly driving the drinking. Careful medication management. A step-down plan built for your actual life, not a generic discharge packet.
The National Institute on Alcohol Abuse and Alcoholism publishes a standard list of ten questions every program should be able to answer 1. Use those as your floor. What follows here is what to ask on top of that floor when you have relapsed before and you need this attempt to be structured differently.
The seven questions ahead are diagnostic. Each one is built to tell you, in about two minutes on the phone, whether a program is genuinely built for treatment-resistant AUD, or whether it is a 30-day model stretched to fill 90 days.
What 90 Days Should Actually Buy You
Think of the extra weeks as time to build things that a 30-day stay cannot physically hold. In a shorter stay, the clock runs out somewhere between stabilizing your body and starting the real work. You detox, you get oriented, you meet your therapist, you start naming what happened to you—and then it’s discharge day. A well-built 90 day alcohol treatment program uses the extra time to move past introductions and into repair.
Clinical guidance for severe AUD describes a full pathway: about three to seven days of medically monitored withdrawal management, then one to three months of residential care, then structured continuing care in the community 16. The residential block is not the whole recovery. It is the middle piece where deeper work becomes possible because you are not managing a job, a household, or a bar three blocks from home.
The reason to ask for a longer stay is not the number itself. It is what the number lets your care team do. A review of continuing care found that patients receiving three months or more of treatment showed significantly better outcomes—less substance use, better functioning—than those with less than three months 2. That gain does not come from sitting on a couch for extra weeks. It comes from what the weeks are used for.
Here is a working list of what those extra weeks should buy you:
- A full psychiatric assessment, not just an intake questionnaire, and a treatment plan that names every co-occurring condition by diagnosis.
- Trauma-focused therapy that actually starts, not just gets referenced.
- Time for medications—for AUD and for depression, anxiety, PTSD, or bipolar disorder—to be titrated and steady before you leave.
- A step-down plan built with real appointments on real calendars, not a handout.
- Family or support-system work that reflects your actual living situation.
If a program cannot tell you how the extra weeks translate into extra work, you are looking at a 30-day model with more days added. The next seven questions are how you find out which one you’re calling.

Question 1: How Do You Diagnose and Treat What’s Underneath the Drinking?
Ask this one first. The answer tells you almost everything else.
What you’re listening for is whether the program treats alcohol as the only problem or as the surface of a deeper set of problems. NIAAA is direct that AUD commonly co-occurs with depression, anxiety, PTSD, and other conditions, and that integrated assessment and treatment are the standard of care 4. If your prior treatment sent you home with a sobriety plan but no clear diagnosis or plan for the depression, panic, mood swings, or trauma symptoms you were drinking to quiet, you already know what happens next.
The stakes on this question are not small. In one study of residential dual-diagnosis treatment for adults with AUD and co-occurring mood disorders, monthly intoxication rates dropped by a mean of 88% from baseline, and 68% of participants remained in remission at six to twelve months after discharge 5. That’s a specific population in a specific program design—not a promise for every reader—but it tells you what integrated care can look like when it is actually built into the model rather than bolted on.
A review of ten controlled studies of residential programs serving people with co-occurring substance use and mental disorders reached a plain conclusion: greater levels of integration between addiction and mental health services produced better outcomes than lower levels of integration 13. Ask how integrated this program actually is.
Green flag answers sound like:
- “Every admission gets a full psychiatric evaluation from a psychiatrist or psychiatric nurse practitioner in the first week, and a written treatment plan that names each diagnosis.”
- “Our clinicians are Masters-level and trained in co-occurring disorders. The same team treats your addiction and your mental health, not two teams that don’t talk.”
- “We adjust psychiatric medications during your stay so you leave stable, not still titrating.”
Red flag answers sound like:
- “We focus on the addiction first, then you can address mental health afterward.”
- “We have a psychiatrist available if needed”—with no clear evaluation timeline.
- “We refer out for mental health.”

Question 2: Is This Program Trauma-Informed in Practice, Not Just on the Website?
Every program’s website says “trauma-informed” now. The phrase has been diluted into a marketing bullet. Your job on this call is to find out whether it means anything inside the building.
SAMHSA is specific about what the term actually requires. A trauma-informed program “fully integrates knowledge about trauma into policies, procedures, and practices, while seeking to actively resist retraumatization” 8. That is a operational commitment—safety, trustworthiness, peer support, collaboration, empowerment, cultural responsiveness—baked into how the program runs, not a workshop the staff sat through once.
The reason this matters for you specifically: if you have relapsed before, there is a real chance a piece of your prior treatment felt punitive, exposing, or shame-heavy in ways that made you check out emotionally weeks before you drank again. Client and staff research inside residential alcohol and drug facilities finds that integrating trauma-informed care alongside actual PTSD treatment “may reduce the risk of re-traumatisation” and is viewed by both patients and clinicians as necessary to improve outcomes 14. And a 2025 feasibility study of a trauma-informed residential model found the program was delivered as intended about 88% of the time, with significant reductions in substance involvement and in depression, anxiety, and PTSD symptoms 18. That 88% fidelity number is useful. It gives you a concrete benchmark to ask admissions about: how consistently do you actually deliver your trauma-informed model, week to week?
Green flag answers sound like:
- “Every clinical and support staff member completes trauma-informed care training, and we audit fidelity to make sure it shows up in daily practice.”
- “We do not use seclusion or restraint. We use de-escalation protocols and let patients step out of a group without penalty if they get activated.”
- “Groups are structured so no one is required to share trauma details publicly. Trauma processing happens in individual therapy with a clinician trained in it.”
- “We ask about your prior treatment experiences at intake and adjust your plan to avoid what did not work.”
Red flag answers sound like:
- “All our staff are trauma-informed”—with no description of training, audit, or day-to-day practice.
- “We use confrontation to break through denial.” That is the opposite of trauma-informed.
- Any policy that treats leaving a group, refusing to share, or asking for a break as “noncompliance.”
- “We don’t really deal with trauma here—we focus on the drinking.”
One follow-up question separates the labels from the practice: Can you walk me through what happens when a patient becomes emotionally overwhelmed in a group? A trauma-informed program will describe a calm, specific protocol. A program using the label as decoration will pause, generalize, or tell you it “depends.” You will hear the difference in about ten seconds.
Question 3: Do You Offer PTSD-Specific Therapy Alongside Alcohol Treatment?
Trauma-informed care and PTSD treatment are not the same thing. This is where a lot of programs blur the line, and it matters for you.
Trauma-informed is the environment—how staff treat you, how groups are structured, how a hard moment gets handled. PTSD treatment is a specific, evidence-based therapy that targets the memories and reactions themselves. You want both. Client and staff research inside residential alcohol and drug facilities found that both groups view combining trauma-informed care with actual PTSD-specific therapy as necessary to improve outcomes—one without the other leaves work undone 14.
The therapy to ask for by name is Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure, sometimes shortened to COPE. NIAAA’s review of behavioral treatments for co-occurring AUD and PTSD describes this manual-guided protocol as having demonstrated efficacy for people carrying both conditions at the same time 6. In plain English: instead of making you “get sober first, then deal with the trauma later,” a clinician trained in this approach helps you process the traumatic memories while you are still in active AUD treatment, in a structured, paced way.
If you have never been formally diagnosed with PTSD, ask anyway. Combat exposure, childhood abuse, sexual assault, medical trauma, and losing someone violently can all produce PTSD symptoms that alcohol has been quieting for years. A good program will screen you at intake.
Green flag answers sound like:
- “We screen every admission for PTSD and other trauma-related conditions, and we have clinicians trained in prolonged exposure or a comparable evidence-based protocol.”
- “PTSD treatment runs concurrently with your alcohol treatment, not after. Your therapist coordinates both.”
- “We have specific programming for veterans and for survivors of interpersonal violence.”
Red flag answers sound like:
- “You have to complete the addiction program first before we address trauma.”
- “We do trauma work in group only”—with no individual PTSD protocol available.
- “We’re trauma-informed” as the entire answer to a PTSD-specific question.
If drinking was how you managed something that happened to you, sobriety alone will not resolve it. The next call will look a lot like this one. Ask for the therapy by name.
Question 4: What Advanced Modalities Do You Use Beyond Group and Medication?
This question is where you find out whether a program has kept up with the last decade of AUD research, or whether it is running the same curriculum it ran in 2005 with a fresh coat of paint on the website.
Group therapy, individual counseling, and FDA-approved medications for AUD (naltrexone, acamprosate, disulfiram) are the foundation. You should expect all of them. What you are asking about now is what a program adds when the foundation alone has not been enough for you before.
The one worth learning to ask about by name is transcranial magnetic stimulation, or TMS. In plain English: it is a noninvasive treatment that uses magnetic pulses to stimulate specific areas of the brain involved in craving and impulse control. A related technique, transcranial direct current stimulation (tDCS), uses a mild electrical current for a similar purpose. A 2024 systematic review and meta-analysis of neuromodulation combined with pharmacotherapy for substance use disorders found a reduction in craving-related measures when TMS or tDCS was added to medication, with an effect size of Hedges’ g = -0.42 19. That is a modest-to-moderate adjunctive effect, drawn from trials across several substance use disorders and not AUD alone. It is not a cure and it is not a substitute for therapy or medication. What it is: a real, measurable extra tool that a small number of programs have integrated, and one worth asking about if craving has been the piece that dismantles your prior recoveries.
Green flag answers sound like:
- “We offer TMS on-site, prescribed and monitored by our psychiatrist, and we use it alongside AUD medications, not instead of them.”
- “We use all three FDA-approved AUD medications and adjust based on how you respond during your stay.”
- “Experiential therapies like art, music, animal-assisted work, and yoga are structured into the week as clinical modalities, not filler activities.”
Red flag answers sound like:
- “We don’t really do medications here—this is a spiritual program.”
- “TMS cures alcoholism.” No, it does not. Anyone selling it that way is selling.
- Vague references to “holistic” or “innovative” care with no specific modality named.
Ask what the program does for craving specifically. If the answer is only “willpower and meetings,” you have your answer.
Question 5: How Do You Monitor Recovery With Biosensors and Remote Tools?
This one is worth asking even if you have never worn a fitness tracker in your life. The answer tells you how a program thinks about what happens between sessions, both inside residential and after you go home.
Two categories are in play. The first is personal sensing during your stay—wearable devices that track sleep, heart rate, stress signals, and activity so your clinical team can see patterns you cannot report from memory. Poor sleep the night before a hard group. A stress spike three days before a craving episode. Those patterns become part of your treatment plan instead of getting lost. The second is remote monitoring for continuing care—smartphone check-ins, ecological momentary assessment (EMA), and app-based tools that stay with you after discharge.
Be careful with the marketing here. A 2025 integrative review of remote monitoring technology in AUD found that smartphone-based tools and EMA have the strongest clinical applicability so far, while wearables specifically “were scarcely tested in interventions” and face real adherence challenges over longer periods 10. A separate systematic review of mHealth and wearable sensors found that roughly half of interventions showed meaningful improvements in cravings or alcohol use, and tools like the A-CHESS app can increase engagement and help predict relapse 11. A review of wearable biosensors specifically documented reductions in days of use and drinks per day in one 12-week study, while noting the technology’s full potential remains unproven 12. Promising. Uneven. Ask how the program actually uses these tools, not whether the brochure mentions them.
Green flag answers sound like:
- “We use wearable data during your stay to inform your daily care plan, and clinicians review it, not just an algorithm.”
- “You’ll leave with an app-based check-in tool, and a real person on our team reviews the alerts.”
- “We’re clear about data privacy—here is what we collect, who sees it, and how long we keep it.”
Red flag answers sound like: “Our AI predicts relapse” with no clinician in the loop, or “we give everyone a wearable” with no explanation of what happens with the data. A device on your wrist that nobody looks at is jewelry.
Question 6: What Does the Step-Down From Residential to Home Actually Look Like?
If you only press hard on one question after the psychiatric one, make it this one. The step-down is where most 90-day gains get quietly undone. You leave the structured building, the schedule disappears, and by week two you are sleeping badly, missing appointments, and telling yourself one drink will help you rest.
The research is blunt about the mechanism. Retention of at least 90 days in residential care was associated with better long-term outcomes specifically when patients also received follow-up mental health services after discharge 17. In the same line of work, longer residential retention was linked to less inpatient mental health treatment and more outpatient mental health services at six months, which in turn tracked with better substance use outcomes 3. The residential stay is not the finish line. It is the launch pad for the outpatient work that determines whether this attempt holds.
A well-built discharge should not hand you a photocopied list of AA meetings and a phone number. Ask the program to walk you through, on the phone right now, what the first ninety days after residential look like on your calendar. You are listening for specifics.
Green flag answers sound like:
- “You’ll step down into partial hospitalization first, usually five days a week, then to intensive outpatient, then to standard outpatient. We book those appointments before you leave.”
- “Your psychiatric prescriber and your therapist follow you across levels, or we do a warm handoff to named clinicians who already have your chart.”
- “We coordinate housing, transportation, and family involvement as part of discharge, not as an afterthought.”
- “You’ll have a named case manager for the first ninety days after residential whose job is to keep you in appointments.”
Red flag answers sound like:
- “We give you a list of resources to follow up on.”
- “Aftercare is a weekly alumni Zoom call.”
- “We can refer you to outpatient providers in your area”—without any coordination, appointment-setting, or record transfer.
- Any answer that treats discharge as an endpoint rather than a transition.
One follow-up separates real step-down from a brochure: What percentage of your patients actually attend their first outpatient appointment after discharge, and how do you track that? A program that measures the handoff can answer. A program that treats residential as the product will change the subject.
If the answers you get here are vague, the extra weeks in residential will not save you. The step-down is the recovery.
Question 7: How Do You Measure Whether Your Program Worked?
Save this one for last, but do not skip it. A program that cannot tell you how it measures success is a program telling you to trust the vibe.
NIAAA’s guidance to families and patients puts outcome tracking on the short list of things every program should be able to answer plainly 1. Ask directly: what do you measure, when do you measure it, and what happens to that data? You are looking for real numbers on real timeframes, not testimonials.
The scope matters, too. Research on dually diagnosed patients in residential SUD care found that programs can be relatively effective at reducing substance use while being less successful at engaging those patients and improving psychiatric outcomes 7. A young-adult COD follow-up study showed a similar split: substance use outcomes at one year looked comparable to SUD-only peers, but psychiatric outcomes drifted worse over time 9. Translation for you: if a program only tracks abstinence, it may be missing the part that unravels you first. Ask what they measure on the mental health side.
Green flag answers sound like:
- “We track abstinence, cravings, depression and anxiety scores, PTSD symptoms, and functioning at intake, discharge, and at 3, 6, and 12 months.”
- “We report our completion rate, our step-down attendance rate, and our 6-month outcomes to leadership, and we can share the ranges with you.”
- “We contact alumni on a set schedule—phone, app check-in, or clinician follow-up—and adjust care if scores slip.”
Red flag answers sound like:
- “Our success rate is 90%”—with no definition, denominator, or timeframe.
- “We don’t really track outcomes past discharge.”
- “Ask our alumni”—as the entire answer.
A program that measures its own work honestly is a program willing to learn from the people it did not help. That is the program you want.
Scoring the Call: How to Use the Green Flag / Red Flag Answers
Here is how to use what you just built. Before you dial, print the seven questions and leave space to write next to each one. On the call, you are not looking for perfect answers. You are looking for specific ones.
Give a program one point for every question where the answer sounds like the green flag examples—named clinicians, named therapies, named timeframes, real numbers. Subtract a point for every red flag answer—vague language, “we refer out,” “we don’t really track that,” or a success rate with no definition attached. A program that lands five or better across the seven questions is probably built for someone with your history. A program that lands three or below is a longer version of what did not work.
One more thing. If the person on the other end gets defensive when you press for specifics, that is data too. A program confident in its clinical model welcomes hard questions 1. You are not being difficult. You are doing the work of recovery before treatment even begins—and that is exactly the person a good program wants to admit.
Start Your Next Step Toward Lasting Recovery
Connect with a specialist to discuss your care options and get support tailored to your journey.

Frequently Asked Questions
Is a 90-day alcohol treatment program better than a 30-day program if I’ve relapsed before?
The evidence points that way, with a condition. Continuing care research links three months or more of treatment with better substance use and functioning outcomes than shorter stays 2. What matters is what those weeks are used for—deeper trauma work, integrated psychiatric care, medication stabilization, and a real step-down plan. Extra days without extra clinical depth is not an upgrade.
What’s the difference between dual diagnosis treatment and a program that just offers a therapist?
Having a therapist on staff is not dual diagnosis care. Integrated treatment means one team diagnosing and treating your AUD and your depression, anxiety, PTSD, or bipolar disorder on the same plan, in the same building. A review of controlled residential studies found that greater levels of integration produced better outcomes than lower integration 13. Ask whether the same clinicians handle both, not whether they refer.
Should I ask about PTSD-specific therapy even if I’ve never been formally diagnosed?
Yes. Alcohol quiets trauma symptoms for years before anyone puts a diagnosis on them. A good program screens every admission for PTSD and can offer evidence-based protocols like concurrent treatment using prolonged exposure, which NIAAA identifies as having demonstrated efficacy for co-occurring AUD and PTSD 6. Asking by name signals you want the actual therapy, not just a trauma-informed environment around it.
Are TMS, neuromodulation, and wearable biosensors standard in 90-day residential programs?
No, and be skeptical of anyone claiming otherwise. TMS combined with pharmacotherapy shows a modest adjunctive benefit for craving in substance use research 19, and mHealth and wearable tools show uneven results, with wearables scarcely tested in interventions 10. These are worth asking about as differentiators, but a program should describe them honestly—how they use them, who reviews the data—not sell them as breakthroughs.
What should the step-down from residential to home actually include?
Named appointments, not a resource list. A well-built step-down moves you from residential into partial hospitalization, then intensive outpatient, then standard outpatient, with mental health follow-up throughout. Retention of at least 90 days in residential care was linked to better long-term outcomes specifically when paired with follow-up mental health services 17. Ask who books the appointments, who follows your chart, and who calls if you miss one.
How do I know if a program is genuinely trauma-informed versus just using the label?
SAMHSA defines trauma-informed care as fully integrating knowledge about trauma into policies, procedures, and practices while actively resisting retraumatization 8. Ask concrete questions: how staff are trained and audited, what happens when a patient is overwhelmed in group, whether sharing trauma details publicly is ever required. Vague reassurance is a red flag. A specific de-escalation protocol answered without hesitation is the sign you want.
References
- Q&As FOR ALCOHOL TREATMENT PROGRAMS. https://alcoholtreatment.niaaa.nih.gov/how-to-find-alcohol-treatment/10-questions-for-alcohol-treatment-programs
- The Continuing Care Model of Substance Use Treatment. https://pmc.ncbi.nlm.nih.gov/articles/PMC4007701/
- Stability of Outcomes Following Residential Drug Treatment For Patients with Co-occurring Disorders. https://pubmed.ncbi.nlm.nih.gov/21804769/
- Mental Health Issues: Alcohol Use Disorder and Common Co-Occurring Conditions. https://www.niaaa.nih.gov/health-professionals-communities/core-resource-on-alcohol/mental-health-issues-alcohol-use-disorder-and-common-co-occurring-conditions
- The effects of residential dual diagnosis treatment on alcohol abuse. https://pubmed.ncbi.nlm.nih.gov/28868159/
- Behavioral Treatments for Alcohol Use Disorder and Post-Traumatic Stress Disorder. https://arcr.niaaa.nih.gov/media/283/download
- Dually diagnosed patients’ responses to substance use disorder treatment. https://pubmed.ncbi.nlm.nih.gov/19540699/
- Trauma-Informed Approaches and Programs. https://www.samhsa.gov/mental-health/trauma-violence/trauma-informed-approaches-programs
- Young Adults with Co-Occurring Disorders: Substance Use Disorder Treatment Response and Outcomes. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968943/
- Current approaches using remote monitoring technology in alcohol use disorder (AUD): an integrative review. https://pubmed.ncbi.nlm.nih.gov/40501058/
- Leveraging mHealth and Wearable Sensors to Manage Alcohol Use Disorders: A Systematic Literature Review. https://pmc.ncbi.nlm.nih.gov/articles/PMC9498895/
- A Review of Wearable Biosensors in Alcohol Use Disorder Treatment. https://pmc.ncbi.nlm.nih.gov/articles/PMC8019775/
- A review of research on residential programs for people with co-occurring substance use and mental disorders. https://pubmed.ncbi.nlm.nih.gov/15763752/
- Client and staff perceptions of the integration of trauma-informed care and PTSD treatment in residential AOD treatment facilities. https://pmc.ncbi.nlm.nih.gov/articles/PMC10087870/
- Study protocol: implementing and evaluating a trauma-informed model of care in a youth residential substance use treatment service. https://pmc.ncbi.nlm.nih.gov/articles/PMC10572352/
- Early Intervention, Treatment, and Management of Alcohol Use Disorder. https://www.ncbi.nlm.nih.gov/books/NBK424859/
- Stability of Outcomes Following Residential Drug Treatment for Patients With Co-occurring Disorders. https://pmc.ncbi.nlm.nih.gov/articles/PMC3146302/
- Feasibility and outcomes of a trauma-informed model of care in residential treatment for substance use. https://pubmed.ncbi.nlm.nih.gov/39566885/
- Systematic review and meta-analysis: Combining transcranial magnetic stimulation or direct current stimulation with pharmacotherapy for treatment of substance use disorders. https://pubmed.ncbi.nlm.nih.gov/38273429/